BridgeMD
Tests treatment safety and results for Peripheral Facial Palsy
Official title Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis
ClinicalTrials.gov ID: NCT05547152
What this study is testing
- What it's testing
- Peripheral facial palsy affects 15 to 40 people per 100,000 inhabitants and induces important functional and social repercussions. Synkinesis is a frequent after-effect of facial palsy recovery, consisting of involuntary facial spasms that disturb the gestural harmony and can go as far as a painful hypertonic spasm.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with recent onset peripheral facial palsy (≤ 12 months).
- Patient with peripheral facial palsy of grade ≥ III on the House \& Brackmann score
- Patient of legal age (≥ 18 years)
- Patient with appropriate information and informed consent
You likely can't join if
- Patient with central facial palsy
- Patient with peripheral facial palsy of \> 12 months onset
- Patient with peripheral facial palsy of grade \< III House \& Brackmann score
- Patient who has previously undergone palliative surgery
- Patient undergoing a botulinum toxin injection protocol
- Patients benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons...
See the full eligibility criteria
- Patient with recent onset peripheral facial palsy (≤ 12 months).
- Patient with peripheral facial palsy of grade ≥ III on the House \& Brackmann score
- Patient of legal age (≥ 18 years)
- Patient with appropriate information and informed consent
- Patient with central facial palsy
- Patient with peripheral facial palsy of \> 12 months onset
- Patient with peripheral facial palsy of grade \< III House \& Brackmann score
- Patient who has previously undergone palliative surgery
- Patient undergoing a botulinum toxin injection protocol
- Patients benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection...
- Patients who have not provided informed consent
- Patients with cognitive disorders that do not allow them to follow the proposed self-education protocol
- Blind or visually impaired patients (visual acuity of the better eye after correction ≤ 4/10)
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, Picardie, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, Picardie, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.